Global Immune-Mediated Inflammatory Diseases Treatment Market Size, Status and Forecast 2024-2031

Report ID: 954293 | Published Date: Feb 2026 | No. of Page: 98 | Base Year: 2025 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Targeted biologic therapies
        1.2.3 Novel therapies
    1.3 Market by Application
        1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Pharmacy Store
        1.3.4 Online Pharmacy Stroe
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2016-2027)
    2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Regions
        2.2.1 Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Immune-Mediated Inflammatory Diseases Treatment Industry Dynamic
        2.3.1 Immune-Mediated Inflammatory Diseases Treatment Market Trends
        2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
        2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
        2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue
        3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2016-2021)
        3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
    3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
        3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2020
    3.5 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
    3.6 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
    3.7 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type
    4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2022-2027)

5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application
    5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
    6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
        6.2.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
        6.2.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
        6.2.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
    6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
        6.3.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
        6.3.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
        6.3.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
    6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
        6.4.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
        6.4.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
    7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
        7.2.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
    7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
        7.3.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
    7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
        7.4.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
        8.2.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
        8.3.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region
        8.4.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
    9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
        9.2.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
    9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
        9.3.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
    9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
        9.4.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type
        10.2.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application
        10.3.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country
        10.4.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 Eli Lilly
        11.2.1 Eli Lilly Company Details
        11.2.2 Eli Lilly Business Overview
        11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.2.5 Eli Lilly Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Details
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.3.5 AstraZeneca Recent Development
    11.4 Bristol-Myers
        11.4.1 Bristol-Myers Company Details
        11.4.2 Bristol-Myers Business Overview
        11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.4.5 Bristol-Myers Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Details
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.5.5 Sanofi Recent Development
    11.6 Roche
        11.6.1 Roche Company Details
        11.6.2 Roche Business Overview
        11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.6.5 Roche Recent Development
    11.7 Enlivex Therapeutics
        11.7.1 Enlivex Therapeutics Company Details
        11.7.2 Enlivex Therapeutics Business Overview
        11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.7.5 Enlivex Therapeutics Recent Development
    11.8 Immune Pharmaceuticals
        11.8.1 Immune Pharmaceuticals Company Details
        11.8.2 Immune Pharmaceuticals Business Overview
        11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.8.5 Immune Pharmaceuticals Recent Development
    11.9 Tanabe Pharma
        11.9.1 Tanabe Pharma Company Details
        11.9.2 Tanabe Pharma Business Overview
        11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
        11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
        11.9.5 Tanabe Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Targeted biologic therapies
    Table 3. Key Players of Novel therapies
    Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2016-2021)
    Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2022-2027)
    Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends
    Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
    Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
    Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
    Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2020)
    Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
    Table 21. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. GlaxoSmithKline Company Details
    Table 62. GlaxoSmithKline Business Overview
    Table 63. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product
    Table 64. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 65. GlaxoSmithKline Recent Development
    Table 66. Eli Lilly Company Details
    Table 67. Eli Lilly Business Overview
    Table 68. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product
    Table 69. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 70. Eli Lilly Recent Development
    Table 71. AstraZeneca Company Details
    Table 72. AstraZeneca Business Overview
    Table 73. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product
    Table 74. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 75. AstraZeneca Recent Development
    Table 76. Bristol-Myers Company Details
    Table 77. Bristol-Myers Business Overview
    Table 78. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product
    Table 79. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 80. Bristol-Myers Recent Development
    Table 81. Sanofi Company Details
    Table 82. Sanofi Business Overview
    Table 83. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product
    Table 84. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 85. Sanofi Recent Development
    Table 86. Roche Company Details
    Table 87. Roche Business Overview
    Table 88. Roche Immune-Mediated Inflammatory Diseases Treatment Product
    Table 89. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 90. Roche Recent Development
    Table 91. Enlivex Therapeutics Company Details
    Table 92. Enlivex Therapeutics Business Overview
    Table 93. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product
    Table 94. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 95. Enlivex Therapeutics Recent Development
    Table 96. Immune Pharmaceuticals Company Details
    Table 97. Immune Pharmaceuticals Business Overview
    Table 98. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 99. Immune Pharmaceuticals Recent Development
    Table 100. Tanabe Pharma Company Details
    Table 101. Tanabe Pharma Business Overview
    Table 102. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product
    Table 103. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021) & (US$ Million)
    Table 104. Tanabe Pharma Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Targeted biologic therapies Features
    Figure 3. Novel therapies Features
    Figure 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Hospitals Case Studies
    Figure 6. Pharmacy Store Case Studies
    Figure 7. Online Pharmacy Stroe Case Studies
    Figure 8. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
    Figure 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2020
    Figure 14. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2020
    Figure 16. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
    Figure 20. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
    Figure 21. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
    Figure 22. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2016-2027)
    Figure 38. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 58. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 59. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 60. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 61. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 62. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 63. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 64. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 65. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2016-2021)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Frequently Asked Questions
Immune-Mediated Inflammatory Diseases Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Immune-Mediated Inflammatory Diseases Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Immune-Mediated Inflammatory Diseases Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports